Device Trial Radar · NCT02504424
AirXpanders AeroForm Tissue Expander System for Breast Reconstruction
Last checked: Nov 20, 2026Latest source record: Jan 29, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Nov 12, 2015
Primary completion
May 3, 2017
Study completion Sep 26, 2017
Sponsor
- Lead sponsor
- AirXpanders, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 22, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is designed to allow existing investigators continued access to the AeroForm Tissue Expander to treat patients while AirXpanders completes a marketing application and during the review process by FDA.
Conditions
- Breast Cancer
Interventions
AeroForm Tissue ExpanderDevice
The AeroForm Tissue Expander is a breast tissue expander implanted following mastectomy and activated by remote control to release small doses of carbon dioxide from an internal reservoir to fill and inflate the expander.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Breasts With Successful Tissue Expansion With Exchange to a Permanent Breast Implant Unless Exchange is Precluded by a Non-device Related EventTime frame: 6 months
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Marin General Hospital
Greenbrae, California
Good Samaritan Hospital, San Jose
San Jose, California
Broward Health Medical Center
Fort Lauderdale, Florida
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.